DISCLAIMER:

In the currently posted Lipid Optimization Tool the UPPER STRATUM: CAD, PCI, CABG, TIA/CVA, PVD/bruits, DM (Age > 30) exceeds the CCS Recommendations for the Dx & Tx of Dyslipidemia and Prevention CVD 2006 

Consider more aggressive therapy to a LDL target < 1.8 mmol/L in these populations based on HPS , AVERT , MIRACL, REVERSAL, PROVE-IT and TNT.

Revised NCEP-ATP III Guidelines  include a discretionary LDL target of <70 mg/dL (1.8 mmol/L) for very high risk patients. Circulation. 2004;110:227-239.